Transgenic expression of human cytokines in immunodeficient mice does not facilitate myeloid expansion of BCR-ABL1 transduced human cord blood cells.

about

Transgenic expression of human cytokines in immunodeficient mice does not facilitate myeloid expansion of BCR-ABL1 transduced human cord blood cells.

Item

http://www.wikidata.org/entity/Q42375720

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Transgenic expression of human ...... sduced human cord blood cells.

@en

Transgenic expression of human ...... sduced human cord blood cells.

@nl

type

Item

label

Transgenic expression of human ...... sduced human cord blood cells.

@en

Transgenic expression of human ...... sduced human cord blood cells.

@nl

prefLabel

Transgenic expression of human ...... sduced human cord blood cells.

@en

Transgenic expression of human ...... sduced human cord blood cells.

@nl

P1476

Transgenic expression of human ...... nsduced human cord blood cells

@en

P2093

Carl Högberg

http://www.w3.org/2001/XMLSchema#string

Helena Ågerstam

http://www.w3.org/2001/XMLSchema#string

Marianne Rissler

http://www.w3.org/2001/XMLSchema#string

Nils Hansen

http://www.w3.org/2001/XMLSchema#string

Sofia von Palffy

http://www.w3.org/2001/XMLSchema#string

Thoas Fioretos

http://www.w3.org/2001/XMLSchema#string

P2860

Xenograft models for normal and malignant stem cells

AML xenograft efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3.

OKT3 prevents xenogeneic GVHD and allows reliable xenograft initiation from unfractionated human hematopoietic tissues.

An MDS xenograft model utilizing a patient-derived cell line.

Modeling chronic myeloid leukemia in immunodeficient mice reveals expansion of aberrant mast cells and accumulation of pre-B cells.

Antibodies targeting human IL1RAP (IL1R3) show therapeutic effects in xenograft models of acute myeloid leukemia.

The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity.

AML cells are differentially sensitive to chemotherapy treatment in a human xenograft model.

A xenograft model of macrophage activation syndrome amenable to anti-CD33 and anti-IL-6R treatment.

Dominant-negative Ikaros cooperates with BCR-ABL1 to induce human acute myeloid leukemia in xenografts.

P304

e0186035

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0186035

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

N Landberg

Maria Askmyr

P577

2017-10-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29023488

http://www.w3.org/2001/XMLSchema#string

P932

5638313

http://www.w3.org/2001/XMLSchema#string